Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

AHSAX vs. XLV: which is better?

Bottom line

AHSAX vs XLV: the short answer

AHSAX (Alger Health Sciences Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds.

XLV is cheaper at 0.08% vs 1.17% — a difference of $109 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs −3.0% for AHSAX.

AHSAX has a front-end sales load of up to 5.25%; the other does not.

Updated Nov 19, 2026

AHSAX vs XLV side by side

AHSAXXLV
TypeMutual fundETF
Fund familyAlgerSPDR (State Street)
CategoryHealth Care SectorHealth Care Sector
Expense ratio1.17%0.08%
Annual cost per $10k$117$8
10-yr cost on $10k (prospectus)$1,871$103
Max front load5.25%None
12b-1 fee0.25%0.02%
1-yr return+4.4%+14.5%
5-yr return (annualized)−3.0%+8.1%
10-yr return (annualized)+6.8%+9.8%
Best quarter+24.5%+14.5%
Worst quarter−18.7%−12.7%
Net assets (fund)$75.4M$40.6B
Number of holdings5565
Portfolio turnover289%2%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearAHSAXXLVDifference
2025+10.2%+14.5%−4.4%
2024+1.2%+2.5%−1.3%
2023−4.3%+2.0%−6.3%
2022−17.0%−2.1%−15.0%
2021+2.5%+25.9%−23.4%
2020+31.0%+13.3%+17.7%
2019+22.0%+20.7%+1.4%
2018+5.8%+6.3%−0.5%
2017+37.2%+21.7%+15.5%
2016−3.3%−2.8%−0.5%

Source: Fund prospectus bar charts

Holdings overlap

8 of AHSAX's top 25 holdings also appear in XLV's top 25.

Shared top holdings
HoldingAHSAXXLV
Merck & Company Inc4.18%5.52%
Johnson & Johnson4.06%10.64%
Thermo Fisher Scientific Inc4.00%3.24%
Cvs Health Corp3.67%2.30%
Unitedhealth Group Inc3.61%6.57%
Eli Lilly & Company3.29%16.51%
Abbott Laboratories2.93%2.75%
Vertex Pharmaceuticals Inc1.80%2.19%

Source: SEC Form N-PORT

AHSAX top 10

  1. Dreyfus Treasury Obligations Cash Management — 6.51%
  2. Impulse Dynamics Ireland — 4.27%
  3. Merck & Company Inc — 4.18%
  4. Welltower Inc — 4.12%
  5. Johnson & Johnson — 4.06%
  6. Thermo Fisher Scientific Inc — 4.00%
  7. Bruker Corp — 3.98%
  8. Illumina Inc — 3.95%
  9. Cvs Health Corp — 3.67%
  10. Unitedhealth Group Inc — 3.61%

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

FAQ

What is the difference between AHSAX and XLV?
AHSAX (Alger Health Sciences Fund) and XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) are both mutual funds. XLV is cheaper at 0.08% vs 1.17% — a difference of $109 a year per $10,000 invested.
Which is cheaper, AHSAX or XLV?
XLV has the lower expense ratio (0.08%).
Should I own both AHSAX and XLV?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.